title: An alpha-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes.
authors.forename: Miwako
authors.initials: M
authors.lastname: Tsunosue
authors.forename: Naomi
authors.initials: N
authors.lastname: Mashiko
authors.forename: Yhukou
authors.initials: Y
authors.lastname: Ohta
authors.forename: Yoshito
authors.initials: Y
authors.lastname: Matsuo
authors.forename: Kouichi
authors.initials: K
authors.lastname: Ueda
authors.forename: Masayuki
authors.initials: M
authors.lastname: Ninomiya
authors.forename: Sho-ichi
authors.initials: S
authors.lastname: Tanaka
authors.forename: Masaru
authors.initials: M
authors.lastname: Hoshiko
authors.forename: Yasutsugu
authors.initials: Y
authors.lastname: Yoshiyama
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Takeuchi
authors.forename: Shin-ichiro
authors.initials: S
authors.lastname: Ueda
authors.forename: Sho-ichi
authors.initials: S
authors.lastname: Yamagishi
mesh_terms: D020909:Acarbose / Q000627:therapeutic use*; D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D017127:Glycation End Products, Advanced / Q000097:blood*; D005985:Glyceraldehyde / Q000378:metabolism*; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D008297:Male; D008875:Middle Aged; D044967:Serum / Q000737:chemistry
chemical_list: D004791:Enzyme Inhibitors; D017127:Glycation End Products, Advanced; D065089:Glycoside Hydrolase Inhibitors; D005985:Glyceraldehyde; D020909:Acarbose